Both in Pharmaceuticals
Larimar Therapeutics vs Rocket Pharmaceuticals
Over the past year LRMR returned −27.4% and RCKT returned −20.7%; their daily moves had a correlation of 0.32.
LRMR −27.4% RCKT −20.7%Growth of $1, one year, split-adjusted
| Metric | LRMR | RCKT |
|---|---|---|
| Price | $2.76 | $2.61 |
| Market cap | $286.7M | $286.5M |
| Today | +8.66% | +3.98% |
| 1 month | −0.7% | +5.2% |
| 6 months | −33.5% | −32.4% |
| Year to date | −27.6% | −25.6% |
| 1 year | −28.9% | −26.7% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $156.3M | $262.5M |
| Dividend yield | — | — |
| Volatility (60d) | 79.5% | 66.6% |
| Short % of float | 23.8% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).